Document is current
Any future updates will be listed below
-
Authors
Peng, Chengwei https://orcid.org/0000-0003-4381-0268
Oberstein, Paul E. https://orcid.org/0000-0001-5918-6004
- License Information
-
More Information
Article History
Received: 16 March 2025
Accepted: 6 August 2025
First Online: 30 August 2025
Declarations
:
: Chengwei Peng: Consulting or Advisory Role - AbbVie. Paul Oberstein: Consulting or Advisory Role - Amal Therapeutics; AstraZeneca; Ipsen; Janssen Oncology; Loxo/Lilly. Speakers’ Bureau - AstraZeneca. Research Funding - Amal Therapeutics (Inst); Arcus Biosciences (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Zai Lab (Inst). Expert Testimony - Ipsen. Travel, Accommodations, Expenses – Merck.
